Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon P Shriver

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA Network Open|August 8, 2025
Views Toward Pharmacogenomic Testing Among Patients With CancerSharon P Shriver, Sarah Long, Mark E Fleury
The New England Journal of Medicine|January 26, 2019
The Next Phase of Human Gene-Therapy OversightElisa A Hurley, Darby Hull, Sharon P Shriver
JAMA Network Open|February 25, 2026
The Proposed Drug Conditional Approval Pathway and Responses From Cancer SurvivorsLuke W Chen, Sarah Long, Sharon P Shriver, et al.
Cancer|October 18, 2023
Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a surveyKelly Durden, Patricia Hurley, Dorothy L Butler, et al.
Journal of Clinical and Translational Science|October 20, 2025
Assessing populations with access to National Cancer Institute-funded sites using local distance-based service areasSharon P Shriver, Liora Sahar, Vanhvilai L Douangchai Wills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
Cancer|October 18, 2023
Feasibility of institution-agnostic, EHR-integrated regional clinical trial matchingSharon P Shriver, Waddah Arafat, Caroline Potteiger, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA Network Open|August 8, 2025
Views Toward Pharmacogenomic Testing Among Patients With CancerSharon P Shriver, Sarah Long, Mark E Fleury
The New England Journal of Medicine|January 26, 2019
The Next Phase of Human Gene-Therapy OversightElisa A Hurley, Darby Hull, Sharon P Shriver
JAMA Network Open|February 25, 2026
The Proposed Drug Conditional Approval Pathway and Responses From Cancer SurvivorsLuke W Chen, Sarah Long, Sharon P Shriver, et al.
Cancer|October 18, 2023
Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a surveyKelly Durden, Patricia Hurley, Dorothy L Butler, et al.
Journal of Clinical and Translational Science|October 20, 2025
Assessing populations with access to National Cancer Institute-funded sites using local distance-based service areasSharon P Shriver, Liora Sahar, Vanhvilai L Douangchai Wills, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
Cancer|October 18, 2023
Feasibility of institution-agnostic, EHR-integrated regional clinical trial matchingSharon P Shriver, Waddah Arafat, Caroline Potteiger, et al.
Pageof 1